Key facts
- MedMinder’s last known valuation is $108.0M (Aug 2022).
- It has raised $11.5M; the latest was Later Stage VC ($11.5M) in Jan 2025.
- Notable investors include Accelmed.
- Status: Acquired/Merged (Operating Subsidiary).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for MedMinder
- ·The full record, as it builds
Funding rounds
No funding rounds for MedMinder are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MedMinder
Developer of a pill dispensing system designed to simplify medication management. The company's system provides an automated system that encourages medication adherence by surrounding the patient with the assistance of family, friends, and professional caregivers to effect positive behavioral change, enabling patients to maintain their independence and avoid long-term care facilities and hospitalization.
- Sector
- Healthcare
- HQ
- Norwood, MA, United States
- Founded
- 2007
- Employees
- 99
- Website
- medminder.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
MedMinder doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedMinder shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedMinder in its N-PORT filings yet. We sweep new filings monthly.